Home Contact Center Add this

Debiopharm International uses cutting-edge ClinTrial App mobile application from ClinOne in clinical study

ClinTrialApp mobile application to be used to support research sites in Debio 1143 ovarian cancer clinical study

Denver, CO and Lausanne, Switzerland – 23 March, 2017 –ClinTrialApp (ClinOne), a company that provides mobile technologies to accelerate clinical trials and Debiopharm International SA (Debiopharm – www.debiopharm.com), part of Debiopharm Group, a Switzerland-based biopharmaceutical company, announced the deployment of ClinTrialApp mobile technology to support its ovarian cancer clinical trial of Debio 1143.

"We are pleased to announce our use of ClinTrialApp (ClinOne) ... to provide greater support to our clinical research sites"

The collaboration further validates ClinTrialApps (ClinOne) approach for real-time clinical trial content to be delivered to research centers through a mobile application and a web application. "We are pleased to announce our use of ClinTrialApp (ClinOne) - a technology that allows us to provide greater support to our clinical research sites. Clinical research sites are an important element of our clinical development strategy and we would like to lead the way with technology tools that enable them to perform to their full potential", said Mr. Sebastien Del Rizzo, Clinical Trial Manager at Debiopharm International SA.

"We are delighted to collaborate with Debiopharm International and most importantly we are pleased to be providing a mobile technology solution to their research sites which enables them to access clinical trial content at the point-of-care", according to ClinTrialApp (ClinOne) CEO, Rob Bohacs. ClinTrialApp (ClinOne) provides a global mobile platform for research sites to stay connected and access the right study content in a mobile environment. The company manages nearly 2,000 active clinical trials across 34 countries through its technology.

About Debiopharm International SA
Debiopharm Group™ is a Swiss-headquartered global biopharmaceutical group of five companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics tools and investment management. Debiopharm International SA is focused on the development of prescription drugs that target unmet medical needs. The company in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide.
For more information, please visit www.debiopharm.com 
We are on Twitter. Follow us @DebiopharmNews at http://twitter.com/DebiopharmNews 

About ClinTrialApp (ClinOne)
ClinTrialApp (ClinOne), based in Denver, CO, is a mobile technology company dedicated to transitioning research into a mobile environment to significantly improve how researchers and patients interact and engage with clinical trials. The company offers a full suite of mobile technologies to centralize research and deliver the needed clinical trial content to the right participants. ClinOne information platform aims to improve day-to-day engagement of clinicians, academic researchers, drug developers and patients to help advance drug and medical device clinical trials.
For more information, please visit www.clintrialapp.com 

pdfPrinter-friendly version

Debiopharm International SA Contact
Christelle Tur
Communication Coordinator
christelle.tur@debiopharm.com
Tel: +41 (0)21 321 01 11